Status:
UNKNOWN
Evaluation of Immune Response in COVID-19 Patients
Lead Sponsor:
Azienda Ospedaliera Universitaria Integrata Verona
Conditions:
Allergy and Immunology
Infection Viral
Eligibility:
All Genders
18-90 years
Brief Summary
The aim of the project is to evaluate the immunological features of COVID-19 patients. Patients are recruited without any pharmacological treatments restriction. The number of samples is estimated on ...
Detailed Description
PURPOSES 1. Determine the frequency of circulating immune cells (i.e. T cells, B cells, Neutrophils, Monocytes absolute numbers) in COVID-19 patients at Hospital Trust of Verona. 2. Determine the pla...
Eligibility Criteria
Inclusion
- Hospitalized adults affected by SARS-CoV-2. These patients can be enrolled also for other clinical studies such as off-label or compassionate treatments.
Exclusion
- Patients that withdraw informed consent
Key Trial Info
Start Date :
March 26 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 26 2020
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04438629
Start Date
March 26 2020
End Date
November 26 2020
Last Update
June 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Azienda Ospedaliera Universitaria Integrata Verona
Verona, Italy, 37126